Health In Tech (Nasdaq: HIT), a leading AI-powered Insurtech platform, has announced a new strategic collaboration with DialCare, a top provider of telehealth and virtual care services. The partnership is set to expand access to virtual primary care and behavioral health across Health In Tech’s nationwide network, as the company continues to redefine the delivery of healthcare through technology-driven innovation.
On-Demand Telemedicine Built Into Self-Funded Plans
Through this integration, employer groups with as few as 10 employees can now offer their teams immediate access to licensed physicians, therapists, and psychiatric providers via DialCare’s mobile app and web platform. The offering includes:
- Virtual primary care
- Therapy and mental health counseling
- Psychiatry services
All services are accessible through Health In Tech’s eDIYBS platform, enabling seamless quoting, enrollment, and benefit management—boosting affordability and efficiency for brokers, TPAs, and self-funded employer groups.
Riding Strong 2025 Momentum
The DialCare partnership builds on Health In Tech’s explosive start to 2025. In the first two months alone, the company generated $5.7 million in unaudited revenue, representing over 50% year-over-year growth and already exceeding revenue from the entire Q1 of 2024.
Expanding Market Reach & Tech-Driven Offerings
This announcement follows Health In Tech’s recent moves to:
- Launch a mid-sized business underwriting solution for employers with over 150 employees
- Release a Spec & Agg stop-loss product to streamline claims for TPAs and carriers
- Partner with MARPAI and Vitable DPC to offer bundled Direct Primary Care and stop-loss plans
Together, these developments represent a bold push to dominate the self-funded insurance space with AI-enabled tools, automation, and value-based care.
About Health In Tech (Nasdaq: HIT)
Health In Tech is a next-gen Insurtech platform transforming self-funded healthcare through automation, third-party AI integration, and simplified benefit administration. Its technology empowers brokers, TPAs, and employers with frictionless access to digital quoting, underwriting, and claims solutions.
As it continues to scale, Health In Tech (NASDAQ: HIT) joins a wave of high-momentum tech and healthcare innovators to watch this week—including: iCoreConnect Inc. (NASDAQ: ICCT), Citius Oncology Inc. (NASDAQ: CTOR), Newton Golf Company Inc. (NASDAQ: NWTG), Treasure Global Inc. (NASDAQ: TGL) and Dyadic International (NASDAQ: DYAI). Investors should add these stocks to their radar now!
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com